Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing.
Malinda. K M KM; Sidhu. G S GS; Banaudha. K K KK; Gaddipati. J P JP; Maheshwari. R K RK; Goldstein. A L AL; Kleinman. H K HK
Key Findings
- Thymosin‑alpha‑1 acts as a strong chemoattractant for endothelial cells and monocytes in vitro.
- Topical or intraperitoneal administration of the peptide increased angiogenesis in a mouse subcutaneous model.
- Both topical and injected thymosin‑alpha‑1 accelerated closure of punch‑type skin wounds in mice.
Practical Outcomes
- For DIY health enthusiasts, thymosin‑alpha‑1 looks promising as a wound‑healing or skin‑repair agent, but the research is still at the animal‑study stage. No human dosage or safety data are provided, so any personal use would be experimental and should be approached with caution. Monitoring emerging human trials would be the next step before incorporating it into a protocol.
Summary
The study shows that thymosin‑alpha‑1, a small peptide from the thymus, can boost the movement of blood‑vessel cells, help new blood vessels form, and speed up wound healing in lab dishes and in mice. It works when applied to the skin or given by injection.
Abstract
In wound healing, lymphoid cells release soluble factors that attract fibroblasts and macrophages, initiating repair, endothelial cell migration, angiogenesis, and matrix production. We analyzed the effect of thymosin alpha1 (Talpha1) on endothelial cell migration, angiogenesis, and wound healing. Talpha1, a 28 amino acid peptide initially isolated from the thymus, enhanced the morphologic differentiation of endothelial cells and was a potent chemoattractant for endothelial cells and monocytes in vitro. In vivo, Talpha1 stimulated angiogenesis in a subcutaneous model. When given either topically or i.p., it accelerated wound healing in a punch model, demonstrating that Talpha1 promotes angiogenesis and wound healing.
Study Information
pubmed
1998
1998-01-15T00:00:00.000Z